Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.4097USD
−5.69 MUSD
8.01 MUSD
5.87 M
About Fresh Tracks Therapeutics, Inc.
Sector
CEO
Albert N. Marchio
Headquarters
Boulder
Website
Employees (FY)
4
Founded
2009
FIGI
BBG000BGNBQ3
Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of FRTX is 0.9002 USD — it has decreased by 1.08% in the past 24 hours. Watch Fresh Tracks Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Fresh Tracks Therapeutics, Inc. stocks are traded under the ticker FRTX.
FRTX stock has fallen by 3.21% compared to the previous week, the month change is a 2.15% fall, over the last year Fresh Tracks Therapeutics, Inc. has showed a 40.65% increase.
FRTX reached its all-time high on Feb 25, 2000 with the price of 23152.5000 USD, and its all-time low was 0.4495 USD and was reached on May 9, 2023. View more price dynamics on FRTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FRTX stock is 1.09% volatile and has beta coefficient of −0.95. Track Fresh Tracks Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Fresh Tracks Therapeutics, Inc. there?
Today Fresh Tracks Therapeutics, Inc. has the market capitalization of 5.44 M, it has increased by 1.09% over the last week.
Yes, you can track Fresh Tracks Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Fresh Tracks Therapeutics, Inc. is going to release the next earnings report on May 24, 2024. Keep track of upcoming events with our Earnings Calendar.
FRTX net income for the last quarter is −1.24 M USD, while the quarter before that showed 1.91 M USD of net income which accounts for −164.92% change. Track more Fresh Tracks Therapeutics, Inc. financial stats to get the full picture.
No, FRTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 25, 2024, the company has 4.00 employees. See our rating of the largest employees — is Fresh Tracks Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fresh Tracks Therapeutics, Inc. EBITDA is −6.28 M USD, and current EBITDA margin is −78.93%. See more stats in Fresh Tracks Therapeutics, Inc. financial statements.
Like other stocks, FRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fresh Tracks Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Fresh Tracks Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Fresh Tracks Therapeutics, Inc. stock shows the sell signal. See more of Fresh Tracks Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.